ID22523A - Formulasi aerosol obat yang mengandung budesonida - Google Patents

Formulasi aerosol obat yang mengandung budesonida

Info

Publication number
ID22523A
ID22523A IDW990102D ID990102D ID22523A ID 22523 A ID22523 A ID 22523A ID W990102 D IDW990102 D ID W990102D ID 990102 D ID990102 D ID 990102D ID 22523 A ID22523 A ID 22523A
Authority
ID
Indonesia
Prior art keywords
budesonides
aerosol formulation
drugs containing
drugs
aerosol
Prior art date
Application number
IDW990102D
Other languages
English (en)
Indonesian (id)
Inventor
Nayna Govind
Philip A Jinks
Danna L Ross
Gary H Ward
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10800599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22523(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of ID22523A publication Critical patent/ID22523A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW990102D 1996-09-27 1997-09-23 Formulasi aerosol obat yang mengandung budesonida ID22523A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9620187.6A GB9620187D0 (en) 1996-09-27 1996-09-27 Medicinal aerosol formulations

Publications (1)

Publication Number Publication Date
ID22523A true ID22523A (id) 1999-10-28

Family

ID=10800599

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990102D ID22523A (id) 1996-09-27 1997-09-23 Formulasi aerosol obat yang mengandung budesonida

Country Status (21)

Country Link
EP (1) EP0932397B2 (cs)
JP (1) JP2001501209A (cs)
KR (1) KR20000048646A (cs)
AR (1) AR009370A1 (cs)
AT (1) ATE320246T1 (cs)
AU (1) AU732985B2 (cs)
BR (1) BR9712125A (cs)
CA (1) CA2266431A1 (cs)
CZ (1) CZ102799A3 (cs)
DE (1) DE69735497T2 (cs)
ES (1) ES2259447T3 (cs)
GB (1) GB9620187D0 (cs)
HU (1) HUP0000795A3 (cs)
ID (1) ID22523A (cs)
MY (1) MY130946A (cs)
NO (1) NO991407L (cs)
PL (1) PL332422A1 (cs)
PT (1) PT932397E (cs)
SK (1) SK38399A3 (cs)
WO (1) WO1998013031A2 (cs)
ZA (1) ZA978303B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CZ303833B6 (cs) 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1949891A1 (en) * 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
AU2005293328B2 (en) 2004-10-12 2010-09-30 Generics (Uk) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
ES2259915B1 (es) * 2005-03-15 2007-12-16 Laboratorio Aldo-Union, S.A. Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
CN103655473A (zh) * 2011-10-27 2014-03-26 江苏长风药业有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN102362859A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN109646400A (zh) * 2018-12-25 2019-04-19 上海信谊百路达药业有限公司 一种布地奈德吸入气雾剂及其制备方法
CN112891328A (zh) * 2021-04-12 2021-06-04 上海方予健康医药科技有限公司 一种吸入用布地奈德混悬液的制备方法
CN113768906B (zh) * 2021-10-25 2023-05-09 上海方予健康医药科技有限公司 新型糖皮质激素吸入气雾剂及药物组件

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5136107A (en) * 1990-06-04 1992-08-04 Ethyl Corporation Process for halogenating aromatic compounds
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69218455T2 (de) 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
AU679511B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
DE4322703A1 (de) * 1993-07-08 1995-01-12 Asta Medica Ag Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
TW283164B (cs) * 1993-09-24 1996-08-11 Du Pont
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
EE9700138A (et) * 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid

Also Published As

Publication number Publication date
HUP0000795A3 (en) 2000-09-28
SK38399A3 (en) 1999-09-10
AR009370A1 (es) 2000-04-12
DE69735497D1 (de) 2006-05-11
WO1998013031A2 (en) 1998-04-02
PL332422A1 (en) 1999-09-13
HUP0000795A2 (hu) 2000-08-28
JP2001501209A (ja) 2001-01-30
GB9620187D0 (en) 1996-11-13
KR20000048646A (ko) 2000-07-25
CZ102799A3 (cs) 1999-07-14
MY130946A (en) 2007-07-31
DE69735497T2 (de) 2006-08-24
BR9712125A (pt) 1999-08-31
ATE320246T1 (de) 2006-04-15
AU732985B2 (en) 2001-05-03
PT932397E (pt) 2006-07-31
ES2259447T3 (es) 2006-10-01
CA2266431A1 (en) 1998-04-02
WO1998013031A3 (en) 1998-08-27
NO991407D0 (no) 1999-03-23
EP0932397B1 (en) 2006-03-15
ZA978303B (en) 1999-03-15
NO991407L (no) 1999-03-23
EP0932397A2 (en) 1999-08-04
EP0932397B2 (en) 2014-04-02
AU4492697A (en) 1998-04-17

Similar Documents

Publication Publication Date Title
ID22523A (id) Formulasi aerosol obat yang mengandung budesonida
EG24044A (en) pharmaceutical formulation of omeprazole
NO985720D0 (no) Aerosol legemiddelformuleringer av formoterol
NO944526D0 (no) Medisinsk aerosolformulering
DE69530325D1 (de) Aerosol-arzneiformulierungen
IT1293803B1 (it) Formulazioni di aerosol medicinali
NO952357D0 (no) Formulering av insulinanaloger
DK1073417T3 (da) Farmaceutisk aerosolformulering
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
NO981008D0 (no) Farmasöytisk formulering
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
ID24259A (id) Formulasi obat yang memiliki pelepasan senyawa aktif terkontrol
BR9600688A (pt) Compostos heterocíclicos aromáticos composição farmacêutica uso de um composto e composição cosmética
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
BR9708790A (pt) Composto uso de um composto e formulação farmacêutica
DE69705628D1 (de) Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
PL328763A1 (en) Misolastin containing pharmaceutical preparations of prolonged action
IL127691A0 (en) Useful formulations of acid addition salt drugs
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
GB9304745D0 (en) Use of pharmaceutical formulations
BR9606066A (pt) Composto e formulação farmacêutica
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions